Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Specialty Devices
Orthopedic Devices
Return to: MDBR Home | Specialty Devices | Orthopedic Devices | News
Search Refinements

Orthopedic Devices News

View news from other Medical Devices sectors:
61-75 of 1583 results
AVEX raises $7.6m in series A financing round to support launch of Footbeat
AVEX announced the securing of $7.6m in series A financing that will fuel the Q1 2017 launch of Footbeat.
Specialty Devices > Orthopedic Devices > News
Johnson & Johnson Medical Devices Companies introduce Orthopaedic Episode of Care Approach
The Johnson & Johnson Medical Devices Companies announced their Orthopaedic Episode of Care Approach, a comprehensive offering under their CareAdvantage capabilities, designed to help health systems and surgeons reduce costs and increase quality to drive improvements in orthopaedic care and achieve the goals of value-based alternative care models.
Specialty Devices > Orthopedic Devices > News
Orthofix’s new bone growth stimulators get CE mark and FDA approval
By MDBR Staff Writer
Orthofix International has secured the US Food and Drug Administration (FDA) clearance and CE mark approval for its next-generation CervicalStim and SpinalStim bone growth stimulators.
Specialty Devices > Orthopedic Devices > News
Globus Medical gets CE mark for Excelsius GPS guidance and navigation system
By MDBR Staff Writer
Musculoskeletal implant manufacturer Globus Medical has secured CE mark approval for Excelsius GPS robotic trajectory guidance and navigation system.
Specialty Devices > Orthopedic Devices > News
DePuy Synthes buys Interventional Spine’s expandable cage technology
By MDBR Staff Writer
Johnson & Johnson’s unit DePuy Synthes Products has signed an asset purchase and development agreement with Interventional Spine, which produces expandable cage and minimally invasive surgery (MIS) technologies for spinal fusion.
Specialty Devices > Orthopedic Devices > News
FDA approves CartiHeal's IDE application for Agili-C implant to treat joint surface lesions
By MDBR Staff Writer
The US Food and Drug Administration (FDA) has approved CartiHeal's investigational device exemption (IDE) application for Agili-C implant to treat joint surface lesions.
Specialty Devices > Orthopedic Devices > News
Allergan to buy Acelity’s LifeCell business unit for $2.9bn
By MDBR Staff Writer
Drugmaker Allergan has agreed to acquire LifeCell, a regenerative medicine unit owned by privately held medical device firm Acelity, for $2.9bn.
Specialty Devices > Orthopedic Devices > News
Meyers & Flowers Law Firm announces new settlement agreement with Stryker
The Multidistrict Litigation (MDL) Plaintiffs’ lead counsel committee, chaired by Peter J. Flowers of Meyers & Flowers, a Chicago-based law firm, reached a new settlement agreement for numerous patients involved in on-going litigation against Stryker and Howmedica Osteonics for complications involving the defective Stryker Modular Rejuvenate and ABG II Femoral Hip Implants.
Specialty Devices > Orthopedic Devices > News
PAVmed seeks US approval for PortIO intraosseous infusion system
Medical device firm PAVmed is seeking approval in the US for its PortIO intraosseous infusion system.
Specialty Devices > Orthopedic Devices > News
Zimmer Biomet adds autograft substitute to spine portfolio
Zimmer Biomet has launched an autograft substitute featuring the similar bone healing elements as autograft.
Specialty Devices > Orthopedic Devices > News
Zimmer Biomet announces early settlement of its cash tender offers for certain outstanding debt securities
Zimmer Biomet Holdings announced that it has completed an offering of €500m aggregate principal amount of 1.414% Notes due 2022 (the "2022 Notes") and €500m aggregate principal amount of 2.425% Notes due 2026 (together with the 2022 Notes, the "Euro Notes") in an SEC registered offering.
Specialty Devices > Orthopedic Devices > News
Tissue Regenix wins technology contract from Premier for bone tissue and synthetic implantable products
Tissue Regenix Wound Care has been awarded a group purchasing contract with Premier for breakthrough technology, including bone tissue and synthetic implantable products.
Specialty Devices > Orthopedic Devices > News
Cesca submits IDE supplement for SurgWerks system trial
Cesca Therapeutics has submitted an investigational device exemption (IDE) supplement to the US Food and Drug Administration (FDA) for its previously approved pivotal trial.
Specialty Devices > Orthopedic Devices > News
Cesca submits IDE supplement for CLI pivotal trial
Cesca Therapeutics, a market leader in automated cellular processing and point-of-care autologous cell-based therapeutics, announced that on November 21, 2016 the Company has submitted an Investigational Device Exemption (IDE) Supplement to the U.S. Food and Drug Administration (FDA) for its previously approved pivotal trial.
Specialty Devices > Orthopedic Devices > News
FDA approves Kyocera Medical’s Initia total hip system
By MDBR Staff Writer
Kyocera Medical has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its Initia total hip system.
Specialty Devices > Orthopedic Devices > News
61-75 of 1583 results